AU7535494A - Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa - Google Patents

Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa

Info

Publication number
AU7535494A
AU7535494A AU75354/94A AU7535494A AU7535494A AU 7535494 A AU7535494 A AU 7535494A AU 75354/94 A AU75354/94 A AU 75354/94A AU 7535494 A AU7535494 A AU 7535494A AU 7535494 A AU7535494 A AU 7535494A
Authority
AU
Australia
Prior art keywords
pharmaceutical preparations
targeted treatment
colitis ulcerosa
morbus crohn
morbus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU75354/94A
Other versions
AU693470B2 (en
Inventor
Ulrich Posanski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU7535494A publication Critical patent/AU7535494A/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Amend patent request/document other than specification (104) Assignors: SANDOZ LTD.
Application granted granted Critical
Publication of AU693470B2 publication Critical patent/AU693470B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Hard or soft gelatin or starch capsules contain an immunosuppressant in dissolved form and are coated with one or more polymer films.
AU75354/94A 1993-09-01 1994-08-10 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa Ceased AU693470B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4329503 1993-09-01
DE4329503A DE4329503A1 (en) 1993-09-01 1993-09-01 Pharmaceutical preparations for the targeted treatment of Crohn's disease and ulcerative colitis
PCT/EP1994/002643 WO1995006464A1 (en) 1993-09-01 1994-08-10 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa

Publications (2)

Publication Number Publication Date
AU7535494A true AU7535494A (en) 1995-03-22
AU693470B2 AU693470B2 (en) 1998-07-02

Family

ID=6496579

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75354/94A Ceased AU693470B2 (en) 1993-09-01 1994-08-10 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa

Country Status (12)

Country Link
EP (2) EP1110545A3 (en)
JP (1) JP3712005B2 (en)
AT (1) ATE207743T1 (en)
AU (1) AU693470B2 (en)
CA (1) CA2170748C (en)
CY (1) CY2340B1 (en)
DE (2) DE4329503A1 (en)
DK (1) DK0716598T3 (en)
ES (1) ES2166781T3 (en)
NZ (1) NZ271655A (en)
PT (1) PT716598E (en)
WO (1) WO1995006464A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH686761A5 (en) 1993-05-27 1996-06-28 Sandoz Ag Pharmaceutical formulations.
EP0673646B1 (en) * 1994-03-22 1998-12-02 Nippon Kayaku Co., Ltd. Use of Deoxypergualin in the manufacture of a medicament for the treatment of inflammatory-hyperresponsiveness diseases
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
GB2303550B (en) * 1994-06-21 1998-07-08 Danbiosyst Uk Colonic drug delivery system
FR2736550B1 (en) 1995-07-14 1998-07-24 Sandoz Sa PHARMACEUTICAL COMPOSITION IN THE FORM OF A SOLID DISPERSION COMPRISING A MACROLIDE AND A VEHICLE
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
EP0978288A4 (en) * 1997-04-11 2006-07-12 Astellas Pharma Inc Medicinal composition
US6030641A (en) * 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same
WO1999049863A1 (en) 1998-03-26 1999-10-07 Fujisawa Pharmaceutical Co., Ltd. Sustained release preparations
AUPP584198A0 (en) * 1998-09-14 1998-10-08 Fujisawa Pharmaceutical Co., Ltd. New use
ATE283689T1 (en) * 1998-09-28 2004-12-15 Warner Lambert Co DRUG DELIVERY INTO THE SMALL AND LARGE INTESTINE USING HPMC CAPSULES
US7030219B2 (en) 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
GB0525546D0 (en) * 2005-12-15 2006-01-25 Novartis Ag Organic compounds
PT2079456E (en) 2007-04-04 2013-03-13 Sigmoid Pharma Ltd Pharmaceutical cyclosporin compositions
WO2008132707A1 (en) 2007-04-26 2008-11-06 Sigmoid Pharma Limited Manufacture of multiple minicapsules
FR2933871B1 (en) * 2008-07-18 2012-12-14 Yvery FORMULATION FOR IMPROVING THE BIOAVAILABILITY OF A HYDROPHOBIC MOLECULE
WO2010122574A2 (en) * 2009-04-20 2010-10-28 Sun Pharma Advanced Research Company Ltd. Coated capsule
BRPI1012196B1 (en) 2009-05-18 2021-11-30 Sublimity Therapeutics Limited COMPOSITION INCLUDING OIL DROPS
GB2485327A (en) 2009-08-12 2012-05-09 Sigmoid Pharma Ltd Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CN107106644B (en) 2014-11-07 2022-04-15 卓越治疗有限公司 Cyclosporin-containing compositions
US20210113479A1 (en) * 2018-05-03 2021-04-22 M.W. Encap Limited Dosage forms for delivery of medicines to the lower gastrointestinal tract

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2340060A1 (en) * 1973-08-08 1975-02-20 Scherer Gmbh R P GELATINE RESISTANT CAPSULES AND METHOD FOR MANUFACTURING THEREOF
BE895724A (en) * 1982-02-01 1983-07-28 Sandoz Sa NEW THERAPEUTIC USE OF DIHYDROCYCLOSPORIN D
SE457505B (en) * 1984-01-10 1989-01-09 Lejus Medical Ab LAMINATED ORAL PHARMACEUTICAL COMPOSITION AND PROCEDURES FOR ITS PREPARATION
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
JPH0211514A (en) * 1988-06-30 1990-01-16 Takara Shuzo Co Ltd Supergualin preparation
US5286730A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory disease
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments

Also Published As

Publication number Publication date
WO1995006464A1 (en) 1995-03-09
ES2166781T3 (en) 2002-05-01
JP3712005B2 (en) 2005-11-02
EP0716598A1 (en) 1996-06-19
PT716598E (en) 2002-04-29
AU693470B2 (en) 1998-07-02
CY2340B1 (en) 2004-02-06
EP0716598B1 (en) 2001-10-31
NZ271655A (en) 1997-09-22
DE59409929D1 (en) 2001-12-06
EP1110545A3 (en) 2001-07-04
JPH09501939A (en) 1997-02-25
DK0716598T3 (en) 2002-02-18
CA2170748C (en) 2008-10-28
CA2170748A1 (en) 1995-03-09
EP1110545A2 (en) 2001-06-27
DE4329503A1 (en) 1995-03-02
ATE207743T1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
AU7535494A (en) Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa
DK0654991T3 (en) Inhalation powder containing antistatic aid
AU2406895A (en) Polymer coated tablet comprising amoxycillin and clavulanate
NZ235807A (en) Controlled release pellet formulation (core coated with or comprising a glucocorticosteroid, and a polymeric outer coating); capsules containing pellets; and use in treating bowel disease
AU1663695A (en) Central venous catheters loaded with antibiotics of the ramoplanin group preventing development of catheter related infections
AU8019994A (en) Lead retention and seal for implantable medical device
AU7545594A (en) Implantable device for the treatment of aedemas
NZ313633A (en) Pharmaceutical composition containing rapamycin in a solid dispersion with a carrier medium
AU7250491A (en) Sterilization and coating apparatus
AU7655691A (en) Grain supplying vessel, grain containing body, and grain assemblage
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
AU3173293A (en) Biaxially oriented high-molecular polyethylene film and production thereof, and surface-modified, biaxially oriented high-molecular polyethylene film and production thereof
AU4263789A (en) Antimalarial compositions and methods of treatment using quinidine, artemisinine and its derivatives
ATE149827T1 (en) SOLID DRUG DOSAGE FORM AND METHOD FOR REDUCING ABRASION
GEP20022629B (en) Sustained-Release Microgranules Containing Diltiazem As The Active Principle and Gelatinous Capsule Containing the Same
RU96118929A (en) METHOD FOR INCREASING PROTECTIVE PROPERTIES OF THE BODY UNDER THE INFLUENCE OF EXTERNAL PHYSICAL FACTORS
CY2427B1 (en) Use of granisetron for the treatment of post-operative nausea and vomiting.
AU3909389A (en) Il-1alpha derivatives and medicament for treating thrombocytopenia
AU3200393A (en) Body tissue omega-3 fatty-acid-augmenting agent and nutrient composition containing the same
CA2082270A1 (en) Anti-viral therapy
AU8611291A (en) Catheter and apparatus for the treatment, inter alia, of pulmonary embolisms
AU4765696A (en) Orienting and conveying flexible or thin articles
AU7144894A (en) Acivicin, derivatives of acivicin, salts of acivicin and salts of derivatives of acivicin as herbicides
EP0676206A4 (en)
AU7511694A (en) Inclusion complexes of racemic ibuproxam and of optically active ibuproxam with cyclodextrin derivatives, process for the preparation thereof, pharmaceutical preparations containing these inclusion complexes or containing optically active s-(+)-ibuproxam, and use thereof